CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry

Introduction: CytoSorb extracorporeal blood purification therapy received FDA Emergency Use Authorization (EUA) to suppress hyperinflammation in critically ill COVID-19 patients. The multicenter CTC Registry was established to systematically collect patient-level data, outcomes, and utilization patt...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Tae Song, Jeremiah Hayanga, Lucian Durham, Lawrence Garrison, Paul McCarthy, Andy Barksdale, Deane Smith, Robert Bartlett, Mark Jaros, Peter Nelson, Zsolt Molnar, Efthymios Deliargyris, Nader Moazami
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2021-12-01
Rangatū:	Frontiers in Medicine
Ngā marau:	coronavirus–COVID-19 ECMO–extracorporeal membrane oxygenation ICU–intensive care unit mortality inflammation hemoperfusion
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fmed.2021.773461/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!